Total Payments
$2,491
2024 Payments
$179.27
Companies
19
Transactions
50
Medicare Patients
2,050
Medicare Billing
$227,741
Payment Breakdown by Category
Food & Beverage$1,925 (77.3%)
Travel$566.44 (22.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,925 | 47 | 77.3% |
| Travel and Lodging | $566.44 | 3 | 22.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic USA, Inc. | $878.12 | 8 | $0 (2019) |
| Nevro Corp. | $391.80 | 3 | $0 (2021) |
| Abbott Laboratories | $316.28 | 3 | $0 (2024) |
| Boston Scientific Corporation | $228.17 | 6 | $0 (2024) |
| MML US, Inc. | $121.66 | 1 | $0 (2022) |
| SPR Therapeutics, Inc | $114.47 | 1 | $0 (2022) |
| Collegium Pharmaceutical, Inc. | $94.70 | 6 | $0 (2019) |
| BIODELIVERY SCIENCES INTERNATIONAL, INC. | $75.11 | 5 | $0 (2020) |
| Horizon Therapeutics plc | $61.76 | 4 | $0 (2020) |
| SI-BONE, INC. | $38.93 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $179.27 | 3 | Boston Scientific Corporation ($142.55) |
| 2023 | $40.38 | 2 | SI-BONE, INC. ($22.70) |
| 2022 | $307.88 | 6 | MML US, Inc. ($121.66) |
| 2021 | $163.07 | 2 | Nevro Corp. ($147.40) |
| 2020 | $114.44 | 7 | Horizon Therapeutics plc ($49.14) |
| 2019 | $516.93 | 19 | Nevro Corp. ($244.40) |
| 2018 | $1,169 | 11 | Medtronic USA, Inc. ($840.87) |
All Payment Transactions
50 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/02/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $21.11 | General |
| Category: Neuromodulation | ||||||
| 01/22/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $142.55 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 01/09/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $15.61 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/29/2023 | AbbVie Inc. | UBRELVY (Drug), BOTOX | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: NEUROSCIENCE | ||||||
| 07/18/2023 | SI-BONE, INC. | — | Food and Beverage | Cash or cash equivalent | $22.70 | General |
| 12/31/2022 | SPR Therapeutics, Inc | SPRINT PNS System (Device) | Food and Beverage | Cash or cash equivalent | $114.47 | General |
| Category: Pain management | ||||||
| 10/31/2022 | SI-BONE, Inc. | — | Food and Beverage | Cash or cash equivalent | $16.23 | General |
| 10/27/2022 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 10/14/2022 | Relievant Medsystems, Inc. | Intracept (Device), Intracept | Food and Beverage | Cash or cash equivalent | $9.78 | General |
| Category: Pain | ||||||
| 06/07/2022 | Relievant Medsystems, Inc. | Intracept (Device), Intracept | Food and Beverage | Cash or cash equivalent | $27.44 | General |
| Category: Pain | ||||||
| 05/25/2022 | MML US, Inc. | ReActiv8 (Device) | Food and Beverage | Cash or cash equivalent | $121.66 | General |
| Category: Pain Management | ||||||
| 10/07/2021 | Nevro Corp. | Omnia (Device) | Food and Beverage | In-kind items and services | $147.40 | General |
| Category: Spinal Cord Stimulator | ||||||
| 01/29/2021 | BOSTON SCIENTIFIC CORPORATION | GENERAL PAIN MANAGEMENT (Device) | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: PAIN MANAGEMENT | ||||||
| 10/17/2020 | Stryker Corporation | IVS - VERTEBRAL AUGMENTATION PRODUCTS (Device) | Food and Beverage | Cash or cash equivalent | $12.75 | General |
| Category: INTERVENTIONAL SPINE | ||||||
| 03/05/2020 | Boston Scientific Corporation | GENERAL - PAIN MANAGEMENT (Device) | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: PAIN MANAGEMENT | ||||||
| 02/21/2020 | BIODELIVERY SCIENCES INTERNATIONAL, INC. | BELBUCA (Drug) | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: Chronic Pain | ||||||
| 02/18/2020 | Horizon Therapeutics plc | PENNSAID (Drug) | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: PENNSAID | ||||||
| 02/04/2020 | Horizon Therapeutics plc | DUEXIS (Drug) | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: DUEXIS | ||||||
| 01/24/2020 | BIODELIVERY SCIENCES INTERNATIONAL, INC. | BELBUCA (Drug) | Food and Beverage | In-kind items and services | $20.85 | General |
| Category: Chronic Pain | ||||||
| 01/21/2020 | Horizon Therapeutics plc | DUEXIS (Drug) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: DUEXIS | ||||||
| 12/20/2019 | BioDelivery Sciences International, Inc. | BUNAVAIL 2.1 mg 30-count box (Drug), BUNAVAIL 2.1 mg single pouch, BUNAVAIL 4.2 mg 30-count box | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: Addiction Therapy | ||||||
| 11/15/2019 | Boston Scientific Corporation | GENERAL PAIN MANAGEMENT (Device) | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: PAIN MANAGEMENT | ||||||
| 11/07/2019 | BioDelivery Sciences International, Inc. | BUNAVAIL 2.1 mg 30-count box (Drug), BUNAVAIL 2.1 mg single pouch, BUNAVAIL 4.2 mg 30-count box | Food and Beverage | In-kind items and services | $11.35 | General |
| Category: Addiction Therapy | ||||||
| 11/05/2019 | ARBOR PHARMACEUTICALS, INC. | Horizant (Drug) | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: Sleep | ||||||
| 11/01/2019 | Medtronic USA, Inc. | SYNCHROMED (Device) | Food and Beverage | In-kind items and services | $37.25 | General |
| Category: Drug Infusion Systems | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 614 | 803 | $493,166 | $65,089 |
| 2022 | 12 | 685 | 960 | $454,888 | $71,362 |
| 2021 | 13 | 584 | 776 | $440,072 | $72,673 |
| 2020 | 5 | 167 | 222 | $115,600 | $18,617 |
Total Patients
2,050
Total Services
2,761
Medicare Billing
$227,741
Procedure Codes
48
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 166 | 244 | $83,936 | $22,172 | 26.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 178 | 178 | $94,874 | $20,855 | 22.0% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2023 | 30 | 38 | $44,415 | $3,350 | 7.5% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2023 | 12 | 20 | $37,664 | $3,082 | 8.2% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Facility | 2023 | 27 | 30 | $34,965 | $2,696 | 7.7% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Office | 2023 | 12 | 17 | $30,816 | $2,535 | 8.2% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2023 | 13 | 21 | $30,381 | $2,034 | 6.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 11 | 11 | $7,304 | $1,593 | 21.8% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Facility | 2023 | 13 | 15 | $30,404 | $1,178 | 3.9% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Office | 2023 | 18 | 26 | $13,888 | $1,056 | 7.6% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Office | 2023 | 11 | 19 | $18,585 | $1,029 | 5.5% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Facility | 2023 | 11 | 19 | $15,099 | $815.55 | 5.4% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2023 | 12 | 17 | $12,942 | $767.76 | 5.9% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Facility | 2023 | 17 | 19 | $10,416 | $751.08 | 7.2% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 44 | 77 | $16,401 | $711.44 | 4.3% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Office | 2023 | 39 | 52 | $11,076 | $464.83 | 4.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 176 | 276 | $94,944 | $25,506 | 26.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 193 | 193 | $102,869 | $23,755 | 23.1% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2022 | 56 | 71 | $74,733 | $6,529 | 8.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 45 | 48 | $11,136 | $3,438 | 30.9% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2022 | 15 | 26 | $38,950 | $2,695 | 6.9% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Office | 2022 | 33 | 44 | $22,320 | $1,727 | 7.7% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Office | 2022 | 19 | 21 | $12,180 | $1,502 | 12.3% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Facility | 2022 | 16 | 17 | $17,180 | $1,484 | 8.6% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Office | 2022 | 14 | 25 | $25,488 | $1,464 | 5.7% |
About Dr. Ivan Chew, MD
Dr. Ivan Chew, MD is a Interventional Pain Medicine healthcare provider based in Dallas, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/22/2014. The National Provider Identifier (NPI) number assigned to this provider is 1417377029.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ivan Chew, MD has received a total of $2,491 in payments from pharmaceutical and medical device companies, with $179.27 received in 2024. These payments were reported across 50 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($1,925).
As a Medicare-enrolled provider, Chew has provided services to 2,050 Medicare beneficiaries, totaling 2,761 services with total Medicare billing of $227,741. Data is available for 4 years (2020–2023), covering 48 distinct procedure/service records.
Ad
Practice Information
- Specialty Interventional Pain Medicine
- Other Specialties Pain Medicine
- Location Dallas, TX
- Active Since 04/22/2014
- Last Updated 01/27/2023
- Taxonomy Code 208VP0014X
- Entity Type Individual
- NPI Number 1417377029
Products in Payments
- KYPHON Balloon Kyphoplasty (Device) $631.48
- Proclaim Family of SCS IPGs (Device) $295.17
- Senza Spinal Cord Stimulation System (Device) $244.40
- SYNCHROMED (Device) $215.00
- Omnia (Device) $147.40
- WaveWriter Alpha Prime 16 (Device) $142.55
- ReActiv8 (Device) $121.66
- SPRINT PNS System (Device) $114.47
- XTAMPZA (Drug) $78.29
- DUEXIS (Drug) $45.60
- BUNAVAIL 2.1 mg 30-count box (Drug) $37.86
- BELBUCA (Drug) $37.25
- Intracept (Device) $37.22
- GENERAL PAIN MANAGEMENT (Device) $32.10
- INTELLIS (Device) $31.64
- SPECTRA WAVEWRITER (Device) $22.55
- PROCLAIM (Device) $21.11
- INTELLIS ADAPTIVESTIM (Device) $18.30
- UBRELVY (Drug) $17.68
- Nucynta ER (Drug) $16.41
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Interventional Pain Medicine Doctors in Dallas
Dr. Don Buford, Md, MD
Interventional Pain Medicine — Payments: $106,098
Interventional Pain Medicine $106,098
Dr. Andrew Konen, M.d, M.D
Interventional Pain Medicine — Payments: $14,612
Interventional Pain Medicine $14,612
Dr. Brian Flanagan, M.d, M.D
Interventional Pain Medicine — Payments: $8,006
Interventional Pain Medicine $8,006
Rinoo Shah, M.d, M.D
Interventional Pain Medicine — Payments: $5,870
Interventional Pain Medicine $5,870
Dr. Steven Sloan, Md, MD
Interventional Pain Medicine — Payments: $4,377
Interventional Pain Medicine $4,377
Darren Schuhmacher, Md, MD
Interventional Pain Medicine — Payments: $3,254
Interventional Pain Medicine $3,254